Frederik Huhn and Dr. Katharina Haft discuss how digital non‑contact dispensing is enabling miniaturized, sustainable liquid ...

Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...

The RCMP charged the former CEO of RPX Gold (TSXV: RPX) on April 28 with fraud and forgery in connection with allegedly […] ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...

The latest review outlines how smaller, more flexible reactor designs could reshape where nuclear power is built.

14 July 2025 - A decade after the adoption of the 2030 Agenda for Sustainable Development, the United Nations released today the 10th edition of its annual progress report, The Sustainable Development ...

Infectious diseases contribute substantially to morbidity and mortality in both developing and developed regions worldwide. Delays in diagnosis remain a ...

Minimal residual disease (MRD) is becoming one of the most important response biomarkers in oncology development. Once viewed primarily as a hematologic endpoint, MRD is now influencing broader ...

Nucleai has partnered with Sirona Dx to provide an integrated spatial proteomics solution for pharmaceutical and biotechnology firms for drug development.

Cell-based assay innovation is reshaping how we discover, validate, and de-risk therapeutic candidates across disease areas. This Research Topic invites ...

RT-MALS can provide instantaneous measurements of adenovirus particle size and titer during downstream and fill–finish ...

i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold", or the "Company") is pleased to announce assay results from its recent drilling campaign at the Archimedes Underground Project ...